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Epstein-Barr Virus-Associated
Lymphoepithelioma-Like Gastric
Carcinoma Presenting as a Submucosal
Mass: CT Findings with Pathologic
Correlation
A lymphoepithelioma-like carcinoma, characterized by a carcinoma with heavy
lymphocyte infiltration, is one of the histological patterns observed in patients with
Epstein-Barr virus (EBV)-associated gastric carcinoma. Less than half of invasive
carcinomas with lymphoepithelioma-like histology can grow to make a submu-
cosal mass. These tumors generally have a better prognosis than conventional
adenocarcinomas. We report a case of an EBV-associated lymphoepithelioma-
like gastric carcinoma that presented as a submucosal mass on multi-detector
(MD) CT and correlate them with the pathology. 
ince Eptein-Barr virus (EBV) DNA was first detected in a patient with
undifferentiated lymphoepithelioma-like gastric carcinoma, EBV is
known to be causally associated with gastric carcinomas in a small
percentage of patients (1-5). Lymphoepithelioma-like carcinoma, pathologically
characterized by a tumor that consists of a lymphoid stroma and small nests of cancer
cells, is one of the histological patterns observed in patients with EBV-associated
gastric carcinomas (1-3, 5, 6). The majority of these tumors arising in the stomach
have been reported to be related to EBV infections (2-4).
Sometimes, lymphoepithelioma-like gastric carcinomas invaded the submucosa,
forming a submucosal nodule that consists of cancer cells admixed with lymphoid
stroma (1, 7). The submucosal mass lesion, one of the various appearances of
lymphoepithelioma-like gastric carcinoma, can be misdiagnosed as submucosal tumors,
such as a gastrointestinal stromal tumor (GIST), carcinoid tumor, or glomus tumor.
Here, we describe the multi-detector (MD) CT findings of an EBV-associated
lymphoepithelioma-like gastric carcinoma presenting as a submucosal mass.
CASE REPORT
A 46-year-old man was transferred to our hospital for further evaluation and
management of a gastric lesion that had been detected by gastroscopy during a
medical checkup at a local clinic. The gastroscopy showed an approximately 2.5-cm
sized submucosal mass with two active ulcers on the mucosal surface (Fig. 1A). The
diagnostic impression of the referring physician in the local clinic was a GIST or
lymphoma. After a gastroscopic biopsy of the mucosal ulcer, the gastric lesion was
diagnosed pathologically as an adenocarcinoma at this clinic. 
A contrast-enhanced CT of the abdomen using a 64-MDCT scanner (LightSpeed
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SVCT, GE Healthcare, Milwaukee, WI) was performed at
our hospital. The CT images revealed a 1.5 × 2.5-cm
ovoid mass with contrast enhancement at the lesser
curvature wall of the gastric high body near the cardia (Fig.
1B, C). Because intact overlying mucosa was identified, the
mass was initially thought to be a submucosal tumor such
as a GIST. There was no evidence of perigastric infiltration,
enlarged lymph nodes, or distant metastasis on CT. After
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Fig. 1. 46-year-old man with Epstein-Barr virus-associated
lymphoepithelioma-like gastric carcinoma.
A. Gastroscopy revealed submucosal mass with two mucosal
ulcerations (arrows) in gastric high body near cardia. 
B. Contrast-enhanced axial CT scan shows ovoid enhancing mass
(arrows) in submucosal layer of gastric high body. Note overlying
mucosa with contrast enhancement (arrowheads). 
C. Coronal reformatted image shows submucosal mass with
contrast enhancement near cardia (arrows). Also note overlying
mucosa (arrowheads).
D. Low-power photomicrograph (Hematoxylin & Eosin stain, ×4)
shows tumor infiltration in mucosa (arrows), mucosal ulcerations
(U) and well-demarcated submucosal mass of lymphoid stroma
(arrowheads).
E. High-power photomicrograph (Hematoxylin & Eosin stain, ×
200) shows multifocal small nests of poorly differentiated
adenocarcinomas (arrows) that are uniformly distributed through-
out lymphoid stroma. These findings of pathology were observed in
all of mucosal and submucosal layers.
Ereviewing the clinical information of the biopsy-proven
adenocarcinoma, a gastric carcinoma was included in the
differential diagnosis on the radiological report. However,
because the enhanced mass in the submucosal layer was
not the usual CT finding for a gastric adenocarcinoma,
comparison with the clinical findings of gastroscopy and
pathology was recommended. 
A total gastrectomy was carried out to remove the
gastric mass. The resected specimen appeared as a 2.0 ×
2.5-cm submucosal mass with small elevated lesions and
central ulcerations on the mucosa. On light microscopy,
poorly differentiated adenocarcinoma with extensive
lymphocytic reaction in the mucosa that invaded the
submucosa and subsequently formed a submucosal mass
was confirmed (Fig. 1D, E). The tumor invaded the
subserosal adipose tissue, and was of the diffuse histologi-
cal type (Lauren’s classification). No lymph node metasta-
sis was present. The presence of EBV in gastric tumor cells
was confirmed by performing EBV-encoded RNA-1
(EBER-1) in situ hybridization.
DISCUSSION
An etiologic association between EBV and gastric
carcinoma has been demonstrated by the uniform expres-
sion of EBV in all carcinoma cells and its absence in normal
epithelium or dysplastic lesions (1, 2). EBV-associated
gastric carcinomas have an approximately 9% overall
prevalence and, tend to be located in the cardia and body
of the stomach when compared with conventional gastric
adenocarcinoma (3, 4). These tumors are closely related to
postsurgical gastric stump/remnant cancers (3, 4). In
addition, approximately 15-25% of EBV-associated gastric
carcinomas exhibit the lymphoepithelioma-like pattern,
whereas 86-91% of lymphoepithelioma-like gastric
carcinomas were EBV positive (3, 4). 
Carcinomas with morphologic features similar to
undifferentiated nasopharyngeal carcinomas are
designated as lymphoepithelioma-like carcinomas and
occur in the stomach, salivary gland, lung, and thymus.
The pathologic findings indicate that the tumor cells, which
are arranged in sheets or nests or as isolated cells, are
surrounded by a dense population of non-neoplastic small
lymphocytes (6). 
EBV-associated gastric carcinomas can present as two
histomorphological forms of a lymphoepithelioma-like
carcinoma and a glandular adenocarcinoma, and these
tumors are characteristically accompanied by prominent
lymphocyte infiltration; EBV has been thought of as being
the main cause for the lymphocytic response (1, 2, 8, 9).
The intramucosal lace pattern with lymphocyte infiltration
has been reported to be the most characteristic morpho-
logic feature of EBV-associated gastric carcinomas. In
addition, carcinomas with submucosal invasion had a
lymphoepithelioma-like pattern of the submucosa in 42%
of cases (1). The pathogenesis of the abundant lymphoid
stroma in the submucosal layer remains unclear, but it is
presumed that carcinomas with a lymphocytic reaction in
the mucosa may invade the submucosa, and this lesion in
the submucosa then grows due to the factors associated
with lymphocytic induction, resulting in the formation of a
submucosal mass (1). 
Lymphoepithelioma-like gastric carcinomas have a better
prognosis than other forms of EBV-associated gastric
carcinomas and conventional gastric carcinomas (1, 2, 9,
10). This is because the spread of tumors through the
gastric wall and to the lymph nodes or remote organs may
be prevented by the abundant lymphocytic reaction; that
is, the patient’s inflammatory response may contribute to a
better prognosis in patients with EBV-associated gastric
carcinoma (1, 9). 
Despite its distinct clinicopathologic features, lymphoep-
ithelioma-like gastric carcinomas are not familiar to most
radiologists. In a CT study including 13 EBV-associated
gastric carcinomas, authors concluded that the carcinomas
were generally located in the upper gastric region, with a
large thickness-to-width ratio, or with a bulky mass
projecting from the wall (11). However, the EBV-associ-
ated gastric carcinomas had various appearances on CT
including focal mucosal thickening, marked wall thickening
with contrast enhancement, and bulky mass formation.
These appearances on imaging may overlap with cases of
early gastric carcinoma, advanced gastric carcinoma, and
lymphoma. In another study describing the endoscopic
ultrasonographic findings of four EBV-associated early
gastric carcinomas, hypoechoic submucosal nodules that
corresponded to lymphoid stroma composed of carcinoma
cells and infiltrating lymphocytes were observed in three
cases that invaded the submucosa (7). 
It is difficult to differentiate lymphoepithelioma-like
gastric carcinoma presenting as a submucosal mass from
other gastric submucosal tumors such as a GIST,
neurogenic tumor, and glomus tumor by imaging alone.
However, as noted in the case reported here, a discrepancy
between imaging findings suggestive of a submucosal
tumor and the biopsy results of the adenocarcinoma may
suggest the diagnosis present in this case.
Although mucosal ulceration can be present in both
EBV-associated gastric carcinomas and submucosal tumors,
the ulcerated shape of the advanced EBV-associated
lesions has been thought to be related to the superficial
depressed shape of the early lesions (12). 
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lymphoepithelioma-like carcinoma that developed in the
gastric body presented as an enhancing submucosal mass
with abundant lymphoid stroma admixed with adenocarci-
noma. Because the tumors have unique clinicopathologic
features, understanding the imaging findings and clinical
features of EBV-associated lymphoepithelioma-like
carcinomas is important in the preoperative diagnosis and
in differentiating this entity from other submucosal tumors. 
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